We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Diamondrock Hospitality Co
DRH
$2.63B
| $3.54M | 0.03% |
349,876
-391,689
| -53% | -$3.48M |
|
427
Oracle
ORCL
$331B
| $3.5M | 0.03% |
85,472
-63,368
| -43% | -$2.35M |
|
|
JWN
428
DELISTED
Nordstrom
JWN
| $3.46M | 0.03% |
60,526
-41,243
| -41% | -$2.13M |
|
429
Gartner
IT
$9.41B
| $3.46M | 0.03% |
+38,751
| New | +$3.28M |
|
430
Abbott
ABT
$180B
| $3.45M | 0.03% |
82,508
-578,119
| -88% | -$22.9M |
|
431
SPX Corp
SPXC
$11B
| $3.44M | 0.03% |
229,003
-98,616
| -30% | -$1.05M |
|
432
Allstate
ALL
$66.9B
| $3.4M | 0.03% |
50,483
+40,080
| +385% | +$2.52M |
|
433
Matsons
MATX
$6.37B
| $3.38M | 0.03% |
84,200
+76,525
| +997% | +$3M |
|
|
B
434
DELISTED
Barnes Group Inc.
B
| $3.38M | 0.03% |
+96,378
| New | +$3.19M |
|
435
Watsco Inc
WSO
$14.9B
| $3.36M | 0.03% |
+24,935
| New | +$3.03M |
|
436
MaxLinear
MXL
$6.49B
| $3.35M | 0.03% |
181,267
+98,576
| +119% | +$1.56M |
|
|
HW
437
DELISTED
Headwaters Inc
HW
| $3.35M | 0.03% |
+168,930
| New | +$2.83M |
|
438
Expedia Group
EXPE
$31.2B
| $3.34M | 0.03% |
31,016
-85,935
| -73% | -$9.16M |
|
439
Johnson & Johnson
JNJ
$635B
| $3.34M | 0.03% |
30,866
-104,080
| -77% | -$10.8M |
|
|
CVT
440
DELISTED
CVENT, INC.
CVT
| $3.33M | 0.03% |
+155,856
| New | +$3.68M |
|
441
ExxonMobil
XOM
$651B
| $3.32M | 0.03% |
+39,714
| New | +$3.18M |
|
442
Boston Scientific
BSX
$65.8B
| $3.32M | 0.03% |
+176,318
| New | +$3.1M |
|
|
ALR
443
DELISTED
Alere Inc
ALR
| $3.32M | 0.03% |
65,540
-51,742
| -44% | -$2.48M |
|
444
Franklin Resources
BEN
$16.9B
| $3.31M | 0.03% |
+84,831
| New | +$3M |
|
|
VIAB
445
DELISTED
Viacom Inc. Class B
VIAB
| $3.3M | 0.03% |
79,858
-182,365
| -70% | -$7.24M |
|
|
WUBA
446
DELISTED
58.com Inc
WUBA
| $3.28M | 0.03% |
58,859
+35,591
| +153% | +$1.97M |
|
447
Metallus
MTUS
$873M
| $3.26M | 0.03% |
+358,211
| New | +$2.62M |
|
448
NRG Energy
NRG
$29.8B
| $3.24M | 0.03% |
248,739
-54,165
| -18% | -$619K |
|
|
INXN
449
DELISTED
Interxion Holding N.V.
INXN
| $3.23M | 0.03% |
93,494
| – | – |
|
|
UN
450
DELISTED
Unilever NV New York Registry Shares
UN
| $3.22M | 0.03% |
72,082
+67,229
| +1,385% | +$2.89M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.